Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Omega Therapeutics
Omega Therapeutics
After an obesity deal with Novo, Omega’s new business head is on the hunt for more partners
Pharma Voice
Mon, 06/24/24 - 11:00 am
Omega Therapeutics
Novo Nordisk offers 2 Flagship biotechs up to $1B total for obesity, MASH deals
Fierce Biotech
Thu, 01/4/24 - 10:06 am
Novo Nordisk
Omega Therapeutics
Cellarity
Flagship Pioneering
funding
obesity
NASH
MASH
mRNA non-vaccine therapeutics field set to reach $2 billion by 2028
Clinical Trials Arena
Tue, 11/8/22 - 10:54 am
MRNA
drug development
Moderna Therapeutics
Ultragenyx
Omega Therapeutics
BioNTech
cancer
OTX-2002
Omega Gets FDA Nod to Start First-Ever Epigenomic Controller Trial
BioSpace
Fri, 07/15/22 - 10:59 am
Omega Therapeutics
hepatocellular carcinoma
OTX-2002
epigenomic controllers
clinical trials
Six more biotechs price public debuts just before the start of the weekend
Endpoints
Fri, 07/30/21 - 12:15 pm
IPOs
Tenaya Therapeutics
Immuneering
Rani Therapeutics
IN8Bio
Omega Therapeutics
MaxCyte
Omega Therapeutics adds $126M to move “programmable” drugs closer to the clinic
MedCity News
Tue, 03/30/21 - 11:55 am
Omega Therapeutics
R&D
programmable drugs
cancer